Novartis May Have Buyer(s) For Its Sandoz Unit - Report

According to a German newspaper, Swedish-based investment group EQT and the Struengmann family of Germany are considering a joint move to purchase the Novartis AG's NVS generics outfit, Sandoz, for $21.6 billion.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: M&ANewsHealth CareRumorsGeneralBriefsDrugs Generic
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!